1. Home
  2. GH vs ZTO Comparison

GH vs ZTO Comparison

Compare GH & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.85

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Logo ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO

ZTO Express (Cayman) Inc. each representing one ordinary share.

HOLD

Current Price

$24.09

Market Cap

17.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
ZTO
Founded
2011
2002
Country
United States
China
Employees
N/A
N/A
Industry
Medical Specialities
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
17.3B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
GH
ZTO
Price
$101.85
$24.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
4
Target Price
$102.81
$21.90
AVG Volume (30 Days)
2.1M
2.2M
Earning Date
02-19-2026
03-17-2026
Dividend Yield
N/A
2.54%
EPS Growth
N/A
N/A
EPS
N/A
1.16
Revenue
$902,569,000.00
$6,673,175,085.00
Revenue This Year
$35.23
$12.15
Revenue Next Year
$27.38
$11.36
P/E Ratio
N/A
$20.37
Revenue Growth
30.38
13.17
52 Week Low
$34.88
$16.34
52 Week High
$120.74
$23.81

Technical Indicators

Market Signals
Indicator
GH
ZTO
Relative Strength Index (RSI) 38.60 73.13
Support Level $97.88 $21.69
Resistance Level $118.00 $23.81
Average True Range (ATR) 5.67 0.41
MACD -1.94 0.13
Stochastic Oscillator 11.61 99.79

Price Performance

Historical Comparison
GH
ZTO

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.

Share on Social Networks: